Seeking Alpha

ISIS Pharmaceuticals (ISIS): Q2 EPS of -$0.01 beats by $0.07. Revenue of $47.3M (+91% Y/Y) beats...

ISIS Pharmaceuticals (ISIS): Q2 EPS of -$0.01 beats by $0.07. Revenue of $47.3M (+91% Y/Y) beats by $7.3M. (PR)
Comments (1)
  • Ben Around
    , contributor
    Comments (117) | Send Message
     
    In a normal [?] market ISIS Should open and stay high on this news.
    Will it get back near 13? It should be there.
    If it stays at 12, I will be a buyer.
    6 Aug 2012, 09:04 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|